Navigation Links
Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
Date:2/4/2010

ss="discStyle" type="disc">
  • A pre-tax impairment charge of approximately $140,000 for the remaining value of certain patents purchased in 2005.  Strategic options to sell, license, or otherwise exploit this technology have not materialized and do not appear imminent.
  • An income tax gain of approximately $489,000 created by reversing a portion of the income tax valuation allowance recorded in the third quarter of fiscal year 2009.  In November 2009, a change in the tax law extended the allowable time period of net operating loss carry backs from two to five years.  This enabled the Company to use the benefits and file for a refund for the 2004 and 2005 tax years.

    • These two non-recurring items created a net $0.04 per share profit in the quarter.

    During the second quarter of fiscal year 2010, the Company continued to strengthen its balance sheet, generating an additional $561,000 of operating cash.  In the first six months of fiscal year 2010, the Company generated $971,000 in operating cash, a significant improvement from the $56,000 in cash used in the first six months of fiscal year 2009. At December 31, 2009, the Company had cash and cash equivalents of $1,790,000 compared to cash and cash equivalents of $1,124,000 as of June 30, 2009 and $406,000 as of December 31, 2008.  The Company’s net debt (total debt less cash) was $1.3 million at December 31, 2009, down from $2.2 million at June 30, 2
    '/>"/>

    SOURCE Pro-Dex, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
    2. PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement
    3. ResMed Inc Announces Record Financial Results for the Quarter and Six Months Ended December 31, 2009
    4. Accuray Announces Results for Second Quarter Fiscal 2010
    5. ATS Medical Announces Fourth Quarter 2009 Earnings Release Date and Conference Call
    6. ADVENTRX Announces Management Promotions
    7. Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China
    8. Genomic Health Announces Year-End 2009 Financial Results
    9. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
    10. Foundation Radiology Group Announces FRG Molecular Imaging Division, Led By Todd M. Blodgett, M.D.
    11. Pulse Systems Announces New Sales Representation in the Western United States
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/17/2013)... 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... has filed a preliminary prospectus supplement to its effective shelf ... similar filing with securities regulatory authorities in each of the ... a public offering of its common shares to raise gross ... Company will also grant to the underwriters of the Offering ...
    (Date:6/17/2013)... , June 17, 2013 Prime Therapeutics, in collaboration ... agency, Larsen, was awarded the Silver Anvil for its internal ... The award was presented at the Public Relations Society of ... June 13 at the AXA Equitable Center in ... Silver Anvil, which has been presented annually since 1946, is ...
    (Date:6/17/2013)... N.J. , June 17, 2013 /PRNewswire-iReach/ -- ... the company,s new X-4S pressure sensitive labeling head. ... stringent speed and performance requirements that serialization demands. ... in, WLS is uniquely qualified to work with ... in their serialization and track and trace implementation ...
    Breaking Medicine Technology:Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2
    ... SAN DIEGO, Oct. 26 Horizon Therapeutics, Inc., ... analysis from two pivotal Phase 3 trials (REDUCE-1 ... a combination of ibuprofen with high-dose famotidine. ... factors for the development of non-steroidal anti-inflammatory drug ...
    ... Executives for Medco Health Solutions, Inc. (NYSE: ... investor conferences: , Timothy Wentworth, Medco,s group president for ... Conference on Wednesday, November 4, 2009 at 2:10 p.m. ... David B. Snow Jr., Medco chairman and CEO, will ...
    Cached Medicine Technology:Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 2Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 3Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 4Medco to Present at November 2009 Investor Conferences 2
    (Date:6/18/2013)... (PRWEB) June 18, 2013 Biomet ... continue to move forward in a multidistrict litigation in ... LLP reports. According to court records, the litigation’s ... at which time the Court also convened a motions ... issues pertinent to the Biomet hip replacement litigation. ...
    (Date:6/18/2013)... Seven-year-old Riley Salz of Encino, California, is ... 40 hours a week of applied behavior analysis (ABA) ... for Autism and Related Disorders (CARD). Riley has been ... experienced remarkable progress, including learning to speak, starting conversations, ... journey through autism is now featured in CARD’s “Mission ...
    (Date:6/18/2013)... Recent research has shown that cancer cells have a ... normal cells. Now, scientists at The University of Texas ... provide a new strategy to combat lung cancer. , ... journal PLOS ONE , UT Dallas researchers compared ... normal lung cells taken from the same patient. ...
    (Date:6/18/2013)... at Case Western Reserve University,s College of Arts ... made available avatarsvirtual patientsto train speech-language pathologists. ... to evaluate speech-language disorders to practice using an ... because a diagnosis doesn,t have to be made ... studying to become speech-language pathologists have previously relied ...
    (Date:6/18/2013)... Belleville, Ill. (PRWEB) June 18, 2013 More ... older are living with HIV/AIDS, according to the Centers for ... don’t know they are infected. In support of National HIV ... Social Security Disability Insurance (SSDI) representation, the CDC ... HIV testing. , The CDC reports about 50,000 new ...
    Breaking Medicine News(10 mins):Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:SimuCase avatars advance speech-language pathology training 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3
    ... boosted hearing in such children , THURSDAY, Feb. ... hearing improvement for children and teens with single-sided deafness, ... 3 percent of children have deafness on one side, ... difficulties and behavioral problems. Traditional external hearing aids are ...
    ... ... NFL Draft pick would have to find a personal trainer, physical therapist, ... them compete with the best athletes in the world. But Athletes, ... offered an NFL Combine preparation program, and this year Trigger Point Performance ...
    ... , Scientists at the Johns Hopkins Kimmel Cancer Center ... cancer patients to develop individualized blood tests they believe ... blood tests, believed to be the first of their ... therapy and determine cancer recurrence., "We believe this ...
    ... It is not unusual to hear people blame their metabolism ... process that shapes how our bodies turn food into energy -- ... fit into your favorite jeans. In fact, differences in ... cells, though the mechanism behind it is unclear. Now new research ...
    ... patients perform significantly better on tests of cognitive function than ... MRI scans of the patients showed that the fitter MS ... show deterioration as a result of MS, as well as ... that aerobic fitness has a protective effect on parts of ...
    ... ... Opinion Survey and Special Supplement on Health Care Reform , ... Indianapolis, IN (Vocus) February 18, 2010 -- ... benefits advisory organizations, today announced the opening of the 2010 UBA Employer Opinion ...
    Cached Medicine News:Health News:Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program 2Health News:Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program 3Health News:Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing 2Health News:Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing 3Health News:Chemical tags likely to affect metabolism, cancer development 2Health News:Exercise helps protect brain of multiple sclerosis patients 2Health News:Exercise helps protect brain of multiple sclerosis patients 3Health News:Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform 2Health News:Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform 3
    Iron / TIBC (Ferrozine). Storage temp: 2 - 8 C. Linearity: 0 - 500 ug/dl. Expected values: from TIBC 250 - 400 ug/dl, from Iron 40 - 160 ug/dl. Available with Calibrator and Number of test are 100....
    For the quantitative determination of iron, total iron-binding capacity in human serum....
    HDL Cholesterol, liquid....
    Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
    Medicine Products: